Therefore, EPA supplementation may be advantageous to cutaneous conditions characterized by up-regulated LOX products and increased inflammatory infiltrate, such as psoriasis, where long-term EPA intake has been shown to be associated with some clinical improvement (47, 48). Here, LOX is linked to psoriasis.